Chapter 1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter 2. Global Next Generation Cancer Diagnostics Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
Chapter 4. Global Next Generation Cancer Diagnostics Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Next Generation Cancer Diagnostics Market by Technology
5.1. Market Snapshot
5.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
5.2.1. NGS-based cancer diagnostics
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2. qPCR & Multiplexing
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4. Protein microarrays-based cancer diagnostics
5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5. DNA microarrays-based cancer diagnostics
5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 6. Global Next Generation Cancer Diagnostics Market by Type
6.1. Market Snapshot
6.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
6.2.1. Lung Cancer
6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2. Breast Cancer
6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.3. Colorectal Cancer
6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.4. Cervical Cancer
6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.5. Others
6.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 7. Global Next Generation Cancer Diagnostics Market by Application
7.1. Market Snapshot
7.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
7.2.1. Biomarker Development
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2. CTC Analysis
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.3. Proteomic Analysis
7.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.4. Epigenetic Analysis
7.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.5. Genetic Analysis
7.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 8. Global Next Generation Cancer Diagnostics Market by Function
8.1. Market Snapshot
8.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
8.2.1. Therapeutic Monitoring
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.2. Companion Diagnostics
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.3. Prognostic Diagnostics
8.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.4. Cancer Screening
8.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.5. Risk Analysis
8.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 9. Global Next Generation Cancer Diagnostics Market, Regional Analysis
9.1. Next Generation Cancer Diagnostics Market, Regional Market Snapshot (2015-2025)
9.2. North America Next Generation Cancer Diagnostics Market Snapshot
9.2.1. U.S. Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2. Canada Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3. Europe Next Generation Cancer Diagnostics Market Snapshot
9.3.1. U.K. Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2. Germany Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3. France Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4. Rest of Europe Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4. Asia Next Generation Cancer Diagnostics Market Snapshot
9.4.1. China Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2. India Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3. Japan Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4. Rest of Asia Pacific Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5. Rest of The World Next Generation Cancer Diagnostics Market Snapshot
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 10. Competitive Intelligence
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Agilent Technologies (Dako)
10.3.3. Almac Group
10.3.4. Cepheid
10.3.5. F. Hoffmann-La Roche Ltd
10.3.6. GE Healthcare
10.3.7. Illumina, Inc.
10.3.8. Janssen Global Services, LLC
10.3.9. Koninklijke Philips N.V.
10.3.10. Novartis AG
10.3.11. Perkin Elmer, Inc.
10.3.12. Qiagen
10.3.13. Thermo Fisher Scientific, Inc.
//
Please note that currency denotation (USD Billion/Million) is provided on the basis of preliminary study, this may change in the final deliverables. Further, shipment values are subject to data availability.
//
List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET
TABLE 3. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION/BILLION)
TABLE 7. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD MILLION/BILLION)
TABLE 8. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD MILLION/BILLION)
TABLE 9. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 1, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 10. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 11. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 2, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 12. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 13. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 3, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 14. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 15. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 4, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 16. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 17. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 5, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 18. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 19. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 6, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 20. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 21. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 7, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 22. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 23. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 8, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 24. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 25. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 9, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 26. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 27. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 10, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 28. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 29. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 11, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 30. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 31. U.S. NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 32. U.S. NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 33. U.S. NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 34. CANADA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 35. CANADA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 36. CANADA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 37. UK NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 38. UK NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 39. UK NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 40. GERMANY NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 41. GERMANY NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 42. GERMANY NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 43. ROE NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 44. ROE NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 45. ROE NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 46. CHINA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 47. CHINA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 48. CHINA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 49. INDIA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 50. INDIA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 51. INDIA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 52. JAPAN NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 53. JAPAN NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 54. JAPAN NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 55. ROAPAC NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 56. ROAPAC NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 57. ROAPAC NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 E 2015-2025 (USD MILLION/BILLION)
TABLE 58. BRAZIL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 59. BRAZIL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 60. BRAZIL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 61. MEXICO NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 62. MEXICO NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT1 2015-2025 (USD MILLION/BILLION)
TABLE 63. MEXICO NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 64. ROLA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 65. ROLA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 66. ROLA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 67. ROW NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 68. ROW NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 69. ROW NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
List of Figures
FIG 1. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, KEY TRENDS 2016
FIG 5. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 1, 2015 & 2025 (USD BILLION)
FIG 10. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT2, 2015 & 2025 (USD BILLION)
FIG 11. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 12. NORTH AMERICA NEXT GENERATION CANCER DIAGNOSTICS MARKET 2015 & 2025 (USD BILLON)
FIG 13. EUROPE NEXT GENERATION CANCER DIAGNOSTICS MARKET 2015 & 2025 (USD BILLON)
FIG 14. ASIA PACIFIC NEXT GENERATION CANCER DIAGNOSTICS MARKET 2015 & 2025 (USD BILLON)
FIG 15. LATIN AMERICA NEXT GENERATION CANCER DIAGNOSTICS MARKET 2015 & 2025 (USD BILLON)
FIG 16. NEXT GENERATION CANCER DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)